Kimberly-Clark Declares Quarterly Dividend
Kimberly-Clark Declares Quarterly Dividend
PR Newswire
DALLAS, Nov. 11, 2026
DALLAS, Nov. 11, 2026 /PRNewswire/ -- The board of directors of Kimberly-Clark Corporation (NASDAQ: KMB) has declared a regular quarterly dividend of $1.28 per share. The dividend is payable in cash on January 5, 2027, to stockholders of record at the close of business on December 4, 2026.

Kimberly-Clark has paid a dividend for 92 consecutive years and has increased its dividend for 54 consecutive years.
The company also announced that it will hold its next annual shareholder meeting on May 13, 2027.
About Kimberly-Clark
Kimberly-Clark (NASDAQ: KMB) is the preeminent global consumer health and wellness leader, built to deliver extraordinary care. Our portfolio of iconic personal care and consumer health brands, including Huggies, Listerine, Cottonelle, Neutrogena, Depend, Tylenol, Kleenex, Johnson's, Kotex and Scott, serves consumers across every stage of life in more than 175 countries. We combine consumer-led innovation, leading brand-building and commercial capabilities, and a fast and agile operating model to raise the standard of care for billions of people around the world. We are committed to using sustainable practices designed to support a healthy planet, build strong communities, and enable our business to thrive for decades to come. The KMB stock is a large cap growth and value stock and core S&P 500 equity held by more than 400 Exchange Traded Funds. Kimberly-Clark is considered a Dividend Aristocrat, having paid a dividend for 92 consecutive years and increasing its dividend in each of the past 54 consecutive years. To keep up with the latest news and learn more about the company's more than 150-year history, visit kimberly-clark.com
[KMB-F]

SOURCE Kimberly-Clark Corporation

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular

4 Growth Stocks to Buy While They’re Still Undervalued

3 of the Best Core Stocks to Own

The 10 Best Companies to Invest in Now

Your Year-End Financial Checklist: 5 Things to Tackle Before 2027

